Related Experiment Video
Updated: Apr 5, 2026

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors
Published on: February 16, 2024
Lipschütz ulcers: should we rethink this? An analysis of 33 cases
Pedro Vieira-Baptista1, Joana Lima-Silva1, Jorge Beires1
1Serviço de Ginecologia e Obstetrícia, Centro Hospitalar de São João, Porto, Portugal.
Objectives:
To describe the presentation and characteristics of patients with Lipschütz ulcers (LU) and to evaluate the role of a standard protocol in the aetiological diagnosis.
Study Design:
Retrospective analysis of all cases of diagnosis of LU at our Vulvar Clinic during a five-year period.
Results:
Of 110 women with vulvar ulcers, 33 (30.0%) had a diagnosis of LU. The mean age was 29.1±15.14 years (10-79 years). Nine (27.3%) were 35 years old or more. The majority had had their sexual debut (28, 84.8%). Ten patients (30.3%) referred had at least one previous similar episode. Twenty-five (75.7%) had non-gynecological symptoms in the week before. The ulcers were located most frequently on the vestibule (19, 57.6%) and the labia minora (10, 30.3%). Isolated lesions on the left side were uncommon (3, 9.1%). Most had multiple (22, 66.7%) lesions. The mean time to full healing of the lesions was 15.6±6.20 days. A microbiological possible cause was identified in 9 (27.3%) patients: CMV (3 cases), Mycoplasma pneumoniae (3 cases), EBV (2 cases) and PVB19 (1 case). The protocol did not include systematic biopsies, blood count differentials, C-reactive protein and liver enzymes, which may have lead to some missed diagnosis.
Conclusions:
LU can be found in women of any age, most of them sexually active. In most cases the lesions are preceded by non-gynecological symptoms and recurrence is common. Most lesions occur on the vestibule and labia minora, being rarely found isolated on the left side. Viruses seem to be the most frequent associated agents but Mycoplasma pneumoniae serology should be considered. In one case there was a possible role for PVB19. A standard protocol can effectively exclude sexually transmitted diseases and lead to a diagnosis in up to a third of cases.
More Related Videos
Related Concept Videos
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Peptic Ulcer
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Pathophysiology of Peptic Ulcer Disease: Injurious Factors
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...

